Fundraising Fox
Relay
NASDAQ: RLAYUnicorn · $1.7BCambridge, US · Founded 2016 · 9 known investors
Find your way into Relay
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jim Caggiano to introduce you to Sanjiv K. Patel
You →Jim · together at Allergan →Sanjiv
Ask Jamie Chen to introduce you to Donald A. Bergstrom
You →Jamie · together at Cellectis →Donald
Sign up to find every way you can get introduced to Relay
- Your email: who you already know at Relay, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Relay team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.
Founders & leadership
Investors · 9
How we know: Commonweal Ventures's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: Nat Turner's portfolio page · Not right? Tell us
.png)
How we know: funding news · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 of 2 rounds · 2024–2026
▶$30MraisedJan 2024 · 1 investors · PharmaceuticalsRule 506(b)
- Thomas CatinazzoExecutive Officer
- Peter RahmerExecutive Officer
- Sekar KathiresanDirector
- Douglas S. IngramDirector
- Sanjiv K. PatelExecutive Officer, Director
- Mark MurckoDirector
- Laura ShawverDirector
- Brian AdamsExecutive Officer
- Linda HillDirector
- Jami RubinDirector
- Donald A. BergstromExecutive Officer
- Alexis BorisyDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Relay do?
- Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques. The platform serves pharmaceutical and biotech researchers seeking to accelerate drug discovery across multiple phases of development.
- Who are Relay's investors?
- Relay's investors include Commonweal Ventures, EcoR1 Capital, Foresite Capital, Nat Turner, Nextech Invest, SoftBank Vision Fund, Curie.Bio, General Catalyst and 1 more.
- How much funding has Relay raised?
- Relay has disclosed $30M raised across 1 of its 2 known rounds.
- Where is Relay headquartered?
- Relay is headquartered in Cambridge, US.